Lavender (Silexan/Oral).

Silexan modulates voltage-gated calcium channels on nerve terminals, damping excess glutamate release. L-theanine shifts cortical activity toward alpha rhythm and raises GABA tone, so calm arrives from two independent routes without added drowsiness.

Magnesium blocks the NMDA receptor channel and competes with calcium at nerve terminals, which is the same excitatory entry point silexan damps. The glycine carrier adds its own inhibitory receptor activity.

Passionflower flavonoids act at the benzodiazepine site of the GABA-A receptor, raising inhibitory tone. Silexan works presynaptically on calcium entry, so inhibition is increased and excitation reduced at once.

Rosmarinic acid in lemon balm inhibits GABA transaminase, so GABA lingers in the synapse. Lavender oil reduces the presynaptic glutamate side of the same balance.

Crocins and safranal influence serotonin reuptake and dopamine handling. Lavender oil acts on a separate presynaptic calcium mechanism, so the pair covers mood tone and excitability without overlapping targets.

Apigenin from chamomile binds the benzodiazepine site of GABA-A with mild partial activity. Combined with silexan's presynaptic action the net excitatory load on the circuit falls further.

Melatonin acts on MT1 and MT2 receptors to signal biological night and shift sleep timing. Lavender oil lowers the arousal that keeps someone from acting on that signal, so the two address different halves of settling down.

Glycine acts at its own inhibitory receptor and lowers core temperature by increasing peripheral blood flow, a normal part of sleep onset. Lavender oil reduces evening arousal by a separate presynaptic mechanism.

Valerenic acid acts at the GABA-A receptor and produces frank sedation at higher doses. Layered on lavender oil the drowsiness adds, so the combination belongs at night and not before driving.

Kavalactones block voltage-gated sodium and calcium channels and enhance GABA-A binding, overlapping directly with silexan's calcium channel action. The sedative effect is additive rather than complementary.

Withanolides moderate the output of the stress axis over weeks of use. Silexan acts within hours on neuronal excitability, so one covers the slow set point and the other the immediate state.

Hops bitter acids modulate GABA-A currents and are long combined with calming botanicals in evening formulas. Added to lavender oil the sedative load rises, which suits bedtime dosing only.

Silexan's constituents act on neuronal excitability without binding the benzodiazepine site, while supplemental GABA acts mainly at peripheral receptors and through vagal signalling given its poor blood-brain barrier penetration. Stacking them is common in calm-focused formulas. The combination has not been measured directly, so the basis is mechanistic overlap rather than a combination trial.

Apigenin is a flavone with documented affinity for the benzodiazepine binding site of GABA-A receptors, a different point of entry from lavender oil's calcium-channel modulation. Formulators pair them for that reason. Additive calm means additive drowsiness, which matters before driving.

Honokiol and magnolol are positive modulators at GABA-A receptors, so a magnolia extract adds a receptor-level action alongside lavender oil's non-GABAergic route. The pairing is standard in evening formulas. Count the sedative load of the whole formula rather than of one ingredient.

Tryptophan is the dietary precursor for serotonin and, downstream, melatonin, supplying substrate to a pathway lavender oil does not feed. The two therefore sit at different points rather than duplicating each other. Precursor supply only helps where substrate is the limiting step.

Pyridoxal 5-phosphate is the cofactor for aromatic L-amino acid decarboxylase and for glutamate decarboxylase, the enzymes that make serotonin and GABA. Without adequate B6 those conversions run slowly whatever else is in the capsule. This is textbook cofactor biochemistry and not a claim about lavender itself.

Taurine is an agonist at glycine and GABA-A receptors and helps stabilise neuronal calcium handling. That overlaps with the calcium-channel end of lavender oil's mechanism while approaching from a different molecule. The pairing is mechanistic; no trial has tested the two together.

Rhodiola is used for daytime stress load and is generally not sedating, which is why formulators put it opposite a calming ingredient rather than alongside one at night. Combining them within a day gives a daytime and an evening arm. Read the pairing as formulation convention, not as a tested interaction.

Bacopa is used for cognitive support over weeks of dosing while lavender oil is used for acute calm, so the two occupy different timescales in a formula. Bacopa can be sedating in some people, adding to that side of the ledger. No combination study exists.

Standardised lavender oil is a lipophilic liquid and is filled into softgels in a triglyceride carrier. Medium-chain triglycerides give a stable, low-viscosity vehicle that keeps the oil dispersed. This is a carrier relationship, not a second active.

Lecithin emulsifies an essential oil into an aqueous or mixed phase and reduces phase separation in a softgel fill. It also softens the eructation that neat volatile oils cause. The role is dispersion, and it makes no contribution to activity.

St John's wort induces CYP3A4 and P-glycoprotein, which accelerates clearance of many co-administered compounds including lipophilic terpenoids. Anything sharing that route is exposed to less drug or less active over time. This is a well characterised induction effect and a reason to space the two rather than stack them.

Caffeine antagonises adenosine receptors and raises arousal, working against an ingredient taken for calm. In practice the two land in different products or different times of day. The opposition is pharmacological and predictable.

Phosphatidylserine is used against the cortisol side of stress load, a different axis from acute neuronal excitability. The two are combined in evening and stress formulas for that reason. The pairing rests on separate mechanisms, not on a study of the combination.